This biphephonol has proven chemopreventive and/or therapeutic effects against prostate cancers, affecting multiple signaling pathways, molecular and cellular targets (e.g., NF-κB, STAT3, EGF receptor, cell survival signaling, cell cycle, cyclooxygenase, and other inflammatory mediators) [263]. The gene discussed is NFKB1; the disease is prostate cancer.